Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

DEFECTIVE DRUGS

Defective Drugs
Facebook Twitter Stumble AddThis Social Bookmark Button Pin It Email to Friend Print Page
Parker Waichman Nursing Home Abuse Mobile App

Get our Defective Drugs app for iOS and Android devices.

Your Personal Injury Lawyer - Parker Waichman LLP Android app on Google Play

Just Because a Doctor Prescribes a Drug Doesn’t Mean It’s not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Today, the pharmaceutical industry is producing drugs aimed at just about every ailment known to man, adding years to nearly everyone’s life, if not outright saving them. They also enable us to live a better-quality lifestyle for a much longer period of time.

Regrettably, some of the drugs these companies manufacture can ultimately prove to be defective, as well as dangerous – and even deadly. Sometimes it may take years for the side effects to even emerge – which means that ultimately some drugs on the market may end up doing more harm than good.

Like any other for-profit corporate entity, pharmaceutical companies are motivated, in varying degrees, by profit. Sometimes profits are more important than people. Anyone who reads the newspaper knows this to be a fact. In many a lawsuit, a pharmaceutical company will be charged with having known full well about some harmful side effect tied to its flagship billion-dollar powerhouse drug – in some instances, many years in advance of this fact’s public disclosure. Companies hide clinical evidence that a drug may be defective in order to gain the U.S. Food and Drug Administration (FDA)’s approval, and to not create obstacles to sales.

Prescription drugs with deadly or dangerous side effects are sometimes rushed to market without adequate testing, and often people are injured or die before the FDA can identify these drugs as having dangerous side effects that can far outweigh whatever benefits the marketing group had touted.

When an FDA classification leads to a drug recall and when an injury occurs, a lawsuit is frequently filed; drug recall lawsuits typically fall into a range of categories, including drug injury, product liability or medical malpractice lawsuits against drug companies.

If you or a loved one have been injured as a result of a prescription drug, you may have valuable legal rights. Parker Waichman LLP urges you to contact us by completing the form at right or call us at 1-800-YOURLAWYER (1-800-968-7529).

To view more information involving a specific defective drug, drug recall, or drug lawsuit, please click on one of the links listed below.

If the defective drug you are looking for is not below, please visit our Defective Drugs Archives page for additional articles about defective drug lawsuits that Parker Waichman LLP has defended for our clients.

To view defective drug videos from our attorneys Click Here.

Tags:  

Defective Drugs

Defective Drugs NewsRSS Feed

Antipsychotic Drug Geodon Carries Risk of Serious, Potentially Fatal Skin Reaction, FDA Says

Dec 16, 2014
The U.S. Food and Drug Administration (FDA) is warning that ziprasidone, an antipsychotic that Pfizer sells under the brand name Geodon, can cause a...

Statins May Increase Risk for Cataracts, Study Finds

Dec 12, 2014
Newly published research in the Canadian Journal of Cardiology  suggests that statins can increase the risk of cataracts. Statins are...

Risk for Acute Kidney Injury with Atypical Antipsychotic Drugs

Dec 10, 2014
Research published in the Annals of Internal Medicine reports several adverse effects, including acute kidney injury (AKI), associated with atypical...

FDA Documents Show Indian Lab Deleted Test Results for Drugs Intended for US

Dec 8, 2014
Food and Drug Administration documents show that in 2011 a quality-control employee of Sun Pharmaceutical Industries Ltd., an Indian drug...

FDA to Make Drug Warning Labels Clearer for Pregnant

Dec 5, 2014
The U.S. Food and Drug Administration (FDA) is improving the often-confusing drug warning labels to make information about use during pregnancy or...

OTC Acetaminophen Drugs to Carry New Warnings of Serious Skin Reactions, FDA Says

Dec 4, 2014
A new draft guidance document issued by the U.S. Food and Drug Administration (FDA) orders new warnings on all over-the-counter (OTC) acetaminophen...

Multiple Sclerosis Drug Tecfidera Linked to Case of PML Brain Infection, FDA Warns

Dec 3, 2014
The multiple sclerosis drug Tecfidera has been linked to a case of a serous brain infection called progressive multifocal leukoencephalopathy (PML),...

Sun Pharma's Effexor Recalled for Second Time in the US

Nov 24, 2014
According to the U.S. Food and Drug Administration (FDA), Sun Pharmaceutical Industries Ltd. has recalled the antidepressant drug Effexor for the...

J&J Reaches $2.2 Billion Settlement to Resolve Allegations over Risperdal, Invega and Natrecor

Nov 19, 2014
According to a press release issued by the Department of Justice Office of Public Affairs, Johnson & Johnson and its subsidiaries will pay $2.2...

Combination of Blood Thinners Linked to Higher Risk of Dementia, Researchers Find

Nov 18, 2014
Research suggests an increased risk of dementia among atrial fibrillation patients who took the anti-clotting drug warfarin in combination with...

Medications the Leading Cause of Sudden Allergy Deaths

Nov 14, 2014
A new study indicates that medications produce far more fatal allergic reactions than either venom or food. Researchers from Albert Einstein College...

Sciecure Rebuked by FDA over Faulty Evidence in Doral Sleeping Pill Ads

Nov 12, 2014
A recent advertisement for Sciecure's Doral sleeping pills sparked concerns by the U.S. Food and Drug Administration. According to the Wall Street...
Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5